Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy-Reference-Cited by-同舟云学术

Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy

Published:2014-08-27 Issue:1 Volume:9 Page:204-217
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Albarakati Nada,Abdel-Fatah Tarek M.A.,Doherty Rachel,Russell Roslin,Agarwal Devika,Moseley Paul,Perry Christina,Arora Arvind,Alsubhi Nouf,Seedhouse Claire,Rakha Emad A.,Green Andrew,Ball Graham,Chan Stephen,Caldas Carlos,Ellis Ian O.,Madhusudan Srinivasan

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference49 articles.

1. Clinicopathological and functional significance of XRCC1 expression in ovarian cancer;Abdel-Fatah;Int. J. Cancer J. Int. du Cancer,2013

2. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy;Abdel-Fatah;Breast Cancer Res. Treat,2013

3. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer;Abdel-Fatah;Breast Cancer Res. Treat,2014

4. DNA polymerase beta deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts;Abdel-Fatah;Mol. Oncol,2014

5. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer;Abdel-Fatah;Mol. Oncol,2014

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the Nrf2/ARE Pathway in the mtDNA Reparation;Frontiers in Bioscience-Landmark;2024-06-18

2. ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma;Neuro-Oncology;2024-03-20

3. Xrcc5/KU80 is not required for the survival or activation of prophase-arrested oocytes in primordial follicles;Frontiers in Endocrinology;2023-10-10

4. Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs;Pharmaceutics;2023-10-08

5. Cellular resistance mechanisms in cancer and the new approaches to overcome resistance mechanisms chemotherapy;Saudi Medical Journal;2023-04